Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.
about
Helping patients to reduce tobacco consumption in oncology: a narrative reviewThe Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of EvidenceEffects of internet-based voucher reinforcement and a transdermal nicotine patch on cigarette smokingA research agenda for assessing the potential contribution of genomic medicine to tobacco control.Cost-effectiveness of extended cessation treatment for older smokersModel-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic reviewAn economic evaluation of a video- and text-based computer-tailored intervention for smoking cessation: a cost-effectiveness and cost-utility analysis of a randomized controlled trialAn analysis of the economic impact of smoking cessation in EuropeAnalytic tools for public health decision making.Combination pharmacotherapy for stopping smoking: what advantages does it offer?Teachable moments for promoting smoking cessation: the context of cancer care and survivorship.The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.Weekly versus basic smoking cessation support in primary care: a randomised controlled trial.Self-help materials for the prevention of smoking relapse: study protocol for a randomized controlled trial.Financial incentives for smoking cessation in low-income smokers: study protocol for a randomized controlled trial.A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessationCost effectiveness analysis of smoking cessation interventions.A comprehensive model for mental health tobacco recovery in new jersey.Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparisonCosts and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.Cost-effectiveness of smoking cessation and the implications for COPD.Extended Self-Help for Smoking Cessation: A Randomized Controlled TrialA review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol.Motivating smokers at outdoor public smoking hotspots to have a quit attempt with a nicotine replacement therapy sample: study protocol for a randomized controlled trialCost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trialEffectiveness of extended-duration transdermal nicotine therapy: a randomized trialPharmacotherapy for smoking cessation.Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?How effective and cost-effective was the national mass media smoking cessation campaign 'Stoptober'?Economic evaluation of pharmaco- and behavioral therapies for smoking cessation: a critical and systematic review of empirical research.Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models.Is there a positive effect of smoking cessation on periodontal health? A systematic review.Mathematical Modeling in Tobacco Control Research: Initial Results From a Systematic Review.The potential of smoking cessation programmes and a smoking ban in public places: comparing gain in life expectancy and cost effectiveness.Racial and Ethnic Disparities in Cardiovascular Disease: An Assessment of Obstetrician-Gynecologists' Knowledge, Attitudes, and Practice Patterns.Abstinence Reinforcement Therapy (ART) for rural veterans: Methodology for an mHealth smoking cessation intervention.Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.
P2860
Q26738416-12BC5592-8A16-4EC2-9333-1655FAEF649AQ26799108-78F164A0-3575-4EC4-B028-CA8B9454AEA8Q28757732-35585CB4-3F8B-4DFB-93F4-6D6E6FA90957Q30230101-83912597-9C6F-4C48-A8C5-F2351D69475AQ33610016-D0E8D3B9-DE09-405A-BC4B-E21B066D1E27Q33697800-2C4E95B5-1C92-4B81-BAEC-F7BCE83FDD84Q34332212-3739E4DC-7540-428D-B8B0-D48A87D6C6A4Q34687287-65FF1913-F8AB-47C3-B73D-E1D8E8B0E337Q34945083-1BEE8940-90FE-4D61-9E58-C754232C6359Q35188753-4A952B8A-EA87-4945-AECB-E6FF3623A912Q35198455-62BC2B6F-E171-4B82-AF06-628E25FEC899Q35538980-21E21E71-5E86-4040-8005-5525C4FBCBA2Q35964545-4A5449C8-3954-461D-AD64-31E812C8DC5BQ36110944-AD4698B0-1EAB-4B52-AF44-78DD1AE9CF95Q36169075-D6F2AAC0-8A54-4F9B-AE74-3D565934A8ABQ36346394-729FE57F-8C6D-4955-AA54-234E674BF21EQ36478377-544E0655-D36F-48A5-97C8-84CC389CC62CQ36481665-C19967A6-6031-48BB-8F73-EBAAF51C45C8Q36638298-B4796E7D-FDC5-498A-93C9-929E2853DB8BQ36800503-47DAD8DF-AEBE-4E3C-A094-6311B00C5130Q36930315-D012133E-B425-4AA1-8F56-EB33AF1CC121Q37005883-C7836365-0D45-481C-B5D2-06126DC5EBFAQ37018832-6D4677B1-93C2-49E1-850E-4CA9C9215858Q37022626-9431A6B1-884E-45F0-AA14-98363D47A97BQ37033602-1D9D621C-EBBE-4350-9354-0C1C94B712E3Q37125635-0B4B6DE4-5217-4E24-AFE1-6798079204A6Q37184340-55E83136-D09C-4D13-AA1A-C4302F223620Q37196970-515F69B5-0785-4370-B842-54C0AA308859Q37362638-220F2FD9-5200-4A78-8918-E4D7A7A122A4Q37519624-0EDF5D28-8A4C-421F-A26B-C12B119C7757Q37592885-2780F930-BAA7-47B0-BB1D-BDDB36C5BA8BQ37648843-89B44009-D391-46F0-BF80-C63EA96E7CD2Q37874333-CF5CF9CB-6EB7-4457-807F-43E55FAA1F2EQ38010473-C981C1FA-FD7F-452F-A7CA-F59D1F60A3F0Q38100276-8C5B032F-13D0-4FAE-A03E-63F74B0A5E84Q38482308-84C57EB4-DB23-4AFC-A9EB-DC18C3A3831EQ39700456-11ECE567-8882-40D5-AA04-10D9985D56CBQ40007867-320DB55E-CCA8-4D25-82E3-492FE7EDC597Q41174891-7D8619AA-2186-49FD-8775-2B9246B80B3BQ41676984-40E3A7AD-B89B-44F3-BEAB-885E001BAE41
P2860
Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@ast
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@en
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@nl
type
label
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@ast
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@en
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@nl
prefLabel
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@ast
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@en
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@nl
P2093
P2860
P356
P1476
Cost-effectiveness of pharmaco ...... a decision analytic analysis.
@en
P2093
Chris Hyde
Fujian Song
James Raftery
Nerys Woolacott
Paul Aveyard
Pelham Barton
P2860
P304
P356
10.1177/027298902237708
P433
P577
2002-09-01T00:00:00Z